Catalyst Pharmaceuticals Appoints Dr. Daniel Curran to Board of Directors
CORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced the
Read MoreCORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced the
Read MoreElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert
Read MorePharma industry execs argue that the President’s MFN order would make the US a less innovation-friendly market. Members of the
Read MoreA variety of generic pills and capsules. Nenov | Moment | Getty Images Pharmaceutical firms are scrambling to respond to
Read MoreDublin – Ireland’s multibillion-euro pharmaceutical industry is still in a precarious position despite this week’s US-EU trade deal. The Trump
Read More30 July 2025 – Servier, an international pharmaceutical company governed by a foundation, and BC Partners, a leading European investment
Read MoreThe obesity drugmaker Novo Nordisk has cut its full-year sales and operating profit forecasts for the second time this year,
Read More07/28/2025 – 09:00 AM Seasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models SANTA MONICA,
Read MoreThis article was written by Follow Daniel Mellado is an economist from Carabobo University with a Master’s Degree in Statistics
Read MoreIndia has established itself as the pharmacy of the world. Supplying nearly 20% of the global generics market and 60%
Read More